Select Committee

2024-01-24 09:45:00+00:00

Oral Evidence Jan. 24 2024

Inquiry: Children, young people and the built environment
Inquiry Status: Closed
Committee: Levelling Up, Housing and Communities Committee (Department: Department for Levelling Up, Housing & Communities)

Found: That stops chronic inflammation, so you get less asthma, eczema, hay fever and inflammatory bowel

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 26 December 2022
Document: Freedom of Information request (FOI 22/1083) - attachment (PDF)

Found: for rheumatoid arthritis (or other types of arthritis except osteoarthritis); Taking medicines for inflammatory

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/996) - attachment 1 (PDF)

Found: disorders NEC Constipation 68 0 Duodenogastric reflux 1 0 Gastrooesophageal reflux disease

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 12 (PDF)

Found: Gastrointestinal atonic and hypomotility disorders NEC Constipation 12 0 Gastrooesophageal reflux disease

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 1 (PDF)

Found: Gastrointestinal atonic and hypomotility disorders NEC Constipation 3 0 Gastrooesophageal reflux disease

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 9 (PDF)

Found: disorders NEC Constipation 68 0 Duodenogastric reflux 1 0 Gastrooesophageal reflux disease

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/1012) - attachment (PDF)

Found: low molecular weight heparin myocardial infarction minutes(s) non-steroidal anti-inflammatory drug

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 24 October 2022
Document: Freedom of Information request (FOI 22/959) - attachment (PDF)

Found: reports received upto and including 28.09.2022 for COVID -19 Pfizer BioNtech vaccine associated with inflammatory

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 10 (PDF)

Found: Gastrointestinal atonic and hypomotility disorders NEC Constipation 3 0 Gastrooesophageal reflux disease

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 4 (PDF)

Found: 1 0 Infrequent bowel movements 1 0 Gastrointestinal disorders NEC Appendix disorder

---